West Pharmaceutical (WST +9.8%) shares break out to an eight-month high after the company issues...

|About: West Pharmaceutical Service... (WST)|By:, SA News Editor

West Pharmaceutical (WST +9.8%) shares break out to an eight-month high after the company issues upside guidance for Q1. WST sees EPS of $0.83, excluding non-recurring items, vs. $0.65 consensus, on revenues of $316M vs. $308M consensus. FY 2012 EPS estimate is raised to $2.50-$2.67 vs. $2.47 consensus.